KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Operating Leases (2019 - 2025)

Historic Operating Leases for CareDx (CDNA) over the last 7 years, with Q3 2025 value amounting to $27.6 million.

  • CareDx's Operating Leases fell 774.57% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year decrease of 774.57%. This contributed to the annual value of $22.3 million for FY2024, which is 2127.1% down from last year.
  • Per CareDx's latest filing, its Operating Leases stood at $27.6 million for Q3 2025, which was down 774.57% from $29.1 million recorded in Q2 2025.
  • CareDx's 5-year Operating Leases high stood at $39.9 million for Q3 2022, and its period low was $17.4 million during Q4 2021.
  • For the 5-year period, CareDx's Operating Leases averaged around $28.2 million, with its median value being $29.1 million (2025).
  • Per our database at Business Quant, CareDx's Operating Leases skyrocketed by 9205.47% in 2022 and then tumbled by 2127.1% in 2024.
  • CareDx's Operating Leases (Quarter) stood at $17.4 million in 2021, then skyrocketed by 92.05% to $33.4 million in 2022, then dropped by 15.35% to $28.3 million in 2023, then fell by 21.27% to $22.3 million in 2024, then rose by 24.17% to $27.6 million in 2025.
  • Its Operating Leases stands at $27.6 million for Q3 2025, versus $29.1 million for Q2 2025 and $30.3 million for Q1 2025.